Home Industries Reports Services About Us Publisher Contact us

Companion Diagnostics Market by Product & Service (Assay kits & Reagents, Software & Services), by Technology (Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), Others (Multiplex Assay and Cellular Imaging Technologies)), by Indication (Cardiovascular, Neurological Diseases, Cancer, Infectious Diseases, Others (inflammatory and inherited diseases)), by End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, CROs, Others (Physicians, Hospitals, Academic Medical Centers, Payers)), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2021 to 2028

Covid-19 Impact on Companion Diagnostics Market

Type: PDF

Status: Published

Categories: Pharma & Healthcare

Report Code : PHC213871

No. of Pages : 350

The report combines brief analysis and deep logical presentation of data together. A detailed study of Companion Diagnostics Market -Global Industry Trend & Analysis market 2028 sand an overview of each segment and its respective sub-segments present in the market are provided in the report. In previous years, the market has undergone high-speed growth and is now expected to grow over the forecast period from 2021 to 2028. The industrial aspects are deeply characterized by both regional and global scale.


Methodology:


Analysis of the Companion Diagnostics study is carried out on various primary and secondary data sources. The primary sources include interviews conducted with numerous market experts, distributors, suppliers, and other professionals involved. The secondary sources include a study of government website statistical data, annual reports of the companies, press releases, and other related documents.


2020 is the base year of the Companion Diagnostics report. 2017 and 2019 are the historic years and 2021 to 2028 are the forecast years. The global market is revenue-based (USD Million/Billion). The report includes the market study based on revenue.


Summary of the Companion Diagnostics Market:


The market has been intensifying the industry and consequently the international economy. The Companion Diagnostics study sheds light on the status of the industry together with outlook aspects to offer interested parties’ avenues to development and take advantage of conditions. It aims to assist users in their specific areas to achieve ecological growth.


The report focuses on the CAGR (Compound Annual Growth Rate) of the global Companion Diagnostics market, the segments, and the regions individually. The market share of the forecast years is valued, based on the CAGR. This prediction of market share is a result of various qualitative and quantitative attributes that influence the parent industry of the product.


The Companion Diagnostics report is categorized segments.


Global Companion Diagnostics Market Analysis and forecast by Product & Service



  • Assay kits & Reagents

  • Software & Services


Global Companion Diagnostics Market Analysis and Forecast by Technology



  • Polymerase Chain Reaction (PCR)

  • In Situ Hybridization (ISH)

  • Next-Generation Sequencing (NGS)

  • Immunohistochemistry (IHC)

  • Others (Multiplex Assay and Cellular Imaging Technologies)


Global Companion Diagnostics Market Analysis and Forecast by Indication



  • Cardiovascular

  • Neurological Diseases

  • Cancer

    • Breast Cancer

    • Lung Cancer

    • Colorectal Cancer

    • Melanoma

    • Gastric Cancer



  • Infectious Diseases

  • Others (inflammatory and inherited diseases)


Global Companion Diagnostics Market Analysis and Forecast by End User



  • Pharmaceutical & Biopharmaceutical Companies

  • Reference Laboratories

  • CROs

  • Others (Physicians, Hospitals, Academic Medical Centers, Payers)


The segments are formulated, based on the method of data synthesis involving a top-down and bottom approach. The top-down analysis involves using comprehensive decision-making factors. It takes the broad market into consideration and then steps down to smaller levels. However, the bottom-down approach, focuses on the market's micro-attributes and then reaches the global market level. A detailed regional classification of the market is also added in the report with their production, revenue, consumption, progress rate and market share, covering:


Global Companion Diagnostics Market Analysis and Forecast By Region



  • North America

    • U.S.

    • Canada

    • Mexico



  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

    • Sweden

    • Russia

    • Switzerland

    • Netherlands

    • Rest Of Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Indonesia

    • Australia

    • Vietnam

    • New Zealand

    • Philippines

    • South Korea

    • Taiwan

    • Singapore

    • Rest Of Asia-Pacific



  • South America

    • Brazil

    • Argentina

    • Rest Of South America



  • Middle East & Africa

    • South Africa

    • U.A.E.

    • Saudi Arabia

    • Rest Of Middle East And Africa




Along with the market share, market standing, market drivers, future trends, opportunities, threats, challenges and entry barriers, anextensive overview of the Companion Diagnostics market is included. In the form of graphs, pie chart, tables, and product estimates, all the brief points and analytical industry data are statistically pictured to provide users with overall information.


The Companion Diagnostics report contains the top and mid-level players and the profiling of the company, along with complete market share data, sales figures and product specifications offered by the leading market companies. The study covers the current market size of the market and its growth rates based on past records with the company outline key manufacturers/players: Moreover, a trade map analysis for import/export capabilities in various regions of the player is conducted.



  • HOFFMANN-LA ROCHE AG

  • AGILENT TECHNOLOGIES, INC.

  • QIAGEN N.V.

  • THERMO FISHER SCIENTIFIC, INC.

  • ABBOTT LABORATORIES, INC.

  • ALMAC GROUP

  • DANAHER CORPORATION

  • ILLUMINA INC.

  • BIOMÉRIEUX SA

  • MYRIAD GENETICS, INC.

  • SYSMEX CORPORATION

  • ABNOVA CORPORATION

  • GUARDANT HEALTH, INC.

  • ICON PLC

  • BIOGENEX LABORATORIES, INC.

  • INVIVOSCRIBE TECHNOLOGIES

  • ARCHERDX, INC.

  • NG BIOTECH

  • Q² SOLUTIONS

  • AMOY DIAGNOSTICS CO., LTD.


Strategy Adoption                                                                               


The report covers detailed information that is essential for the implementation of strategy for an enterprise. The Companion Diagnostics study uses PORTER's five forces for the assessment of entry barriers, comparative analysis of supplier’s and buyer’s power, the intensity of competition, internal and external substitution of the product. Also, different policies are also recommended via PESTEL analysis for clients interested in specific regions.


What Will You Determine From The Companion Diagnostics Study?



  • The Companion Diagnostics study offers statistical analysis of the global market with forecast to 2028.

  • The Companion Diagnostics study provides extensive information on raw material providers, buyers, manufacturers with their commercial outlook over the forecast period.

  • The study explores the significant drivers, technologies, and trends shaping the global market during the forecast period.

  • The study included Companion Diagnostics market segmentation by type, application, and region.

Request For Request Sample

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any), so we can get back to you with a solution

Request For TOC

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any), so we can get back to you with a solution

Request For Research Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any), so we can get back to you with a solution
Zenith Market Insights

Report Code

PHC213871

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Companion Diagnostics Market by Product & Service ...

RD Code : PHC213871